Related Content
April 12, 2012 – Abbott announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next ...
March 29, 2012 – Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and ...
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia ...
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...
March 15, 2012 — According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan ...
Manual compression remains the gold standard of care in sealing interventional access site wounds, but there is a trend ...
December 22, 2011 – Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 9, 2011 — Abbott announced Thursday the initiation of ABSORB II, the first randomized, controlled, multi-center ...
November 15, 2011 – Abbott announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ...
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...